Skip to content

Deficits in cognition in individuals having alcohol abuse with and without having experienced adverse childhood events.

Cognitive Deficits in Alcohol Dependence Syndrome (ADS) Patients with and without Adverse Childhood Experiences (ACE). - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/11/060170
Enrollment
126
Registered
2023-11-22
Start date
Unknown
Completion date
Unknown
Last updated
2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F102- Alcohol dependence

Interventions

Intervention1: nil: nil Control Intervention1: nil: nil

Sponsors

Mota Prachi Himansu Anila
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Group 1 (ADS + ACE) 1. Individuals diagnosed with ADS 2. ADS for minimum 5 years based on ICD-11 Criteria (abstinent for at least 1 week- CIWA score less than 9) 3. Individuals with a frequency score of at least 1 on ACE-IQ 4. Males aged 18- 50 years 5. Abstinence of less than 1 year 6. At least 5 years of formal education (5th standard reading level) and ability to read, write and speak in English or Kannada Group 2 (ACE) 1. Individuals without ADS. 2. Individuals with a frequency score of at least 1on the ACE-IQ 3. Matched group (based of age and education) of males aged 18- 50 years 4. At least 5 years of formal education (5th standard reading level) and ability to read, write and speak in English or Kannada Group 3 (ADS) 1. Individuals diagnosed with ADS 2. ADS for minimum 5 years based on ICD-11 Criteria (abstinent for at least 1 week- CIWA score less than 9) 3. Individuals with a frequency score of 0 on ACE-IQ. 4. Matched group (based of age and education) of males aged 18- 50 years 5. Abstinence of less than 1 year 6. At least 5 years of formal education (5th standard reading level) and ability to read, write and speak in English or Kannada

Exclusion criteria

Exclusion criteria: Group 1 (ADS + ACE) 1. Other substance disorders (except nicotine) 2. Major psychiatric disorders (moderate to severe mood disorders, psychotic disorders, and anxiety disorders) 3. Individuals with severe cognitive deficits, for instance, individuals with Korsakoff’s syndrome, which may hinder the quality and accuracy of data collection. 4. Individuals with major neurological conditions including traumatic brain injury, road traffic accidents, epilepsy. 5. Other major medical comorbidities which may affect cognitive functioning. Group 2 (ACE) 1. Any Disorders due to Substance Use 2. Other major psychiatric disorders (moderate to severe mood disorders, psychotic disorders, and anxiety disorders) 3. Individuals with severe cognitive deficits, for instance, individuals with dementia, which may hinder the quality and accuracy of data collection. 4. Individuals with major neurological conditions including traumatic brain injury, road traffic accidents, epilepsy. 5. Other major medical comorbidities which may affect cognitive functioning. Group 3 (ADS) 1. Individuals with a frequency score of 1 or more on ACE-IQ. 2. Other substance disorders (except nicotine) 3. Major psychiatric disorders (moderate to severe mood disorders, psychotic disorders, and anxiety disorders) 4. Individuals with severe cognitive deficits, for instance, individuals with Korsakoff’s syndrome, which may hinder the quality and accuracy of data collection. 5. Individuals with major neurological conditions including traumatic brain injury, road traffic accidents, epilepsy. 6. Other major medical comorbidities which may affect cognitive functioning.

Design outcomes

Primary

MeasureTime frame
1. Cognitive Control a. Working Memory: Score on Verbal N2-Back Test (hits, omission, commission, error), Digit Span (forward, backward, total) and Spatial Span (forward, backward, total) b. Behavior-Inhibition & Distractor Interference Control: Go/No Go Task (mean accuracy, mean error, response time) 2.Visual Learning & Memory: Scores on Family Pictures Test (Recall 1 & 2, Percent Retention) 3.Verbal Learning & Memory: Scores on Rey’s AVLT (immediate & delayed recall, recognition). Timepoint: Baseline

Secondary

MeasureTime frame
NilTimepoint: Nil

Countries

India

Contacts

Public ContactDiti Kohli

MCHP, MAHE

anagha.deshmukh@manipal.edu7259619947

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026